Multiple Sclerosis Clinical Trial

Management of Pain in Persons With Multiple Sclerosis

Summary

The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

View Full Description

Full Description

This study examined the benefits of two treatments, individually and together, for helping individuals with MS manage their pain. We conducted a time series design in which MS subjects received all four treatment conditions in two orders (randomly assigned): (1) Control (education intervention-CONT),Self-Hypnosis Training (HYP), Cognitive Behavioral Therapy (CBT), HYP-CBT(a combination of HYP and CBT) and (2) CONT, CBT, HYP, HYP-CBT. Subjects attended 16 60-minute treatment sessions conducted by one of the study's psychologists either at the UW,HMC or in the subject's home. Each subject received four treatment sessions of each treatment module listed above. Primary outcome measures were collected via the telephone and mail by research personnel blind to the treatment condition before treatment, immediately after treatment ends and one month after treatment ends. Secondary outcome measures were collected at the same assessment points via pencil and paper interviews completed by subjects.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Chronic ongoing pain (i.e., pain at all times) with an average pain intensity of at least 4/10 on 0-10 numeric rating scale
Pain is either worse or started since the onset of other MS symptoms.
Pain of at least six months duration.
Reads, speaks and understands English.
Definitive diagnosis of multiple sclerosis (MS)
At least 18 years of age
Recruited from a recruitment source approved by the IRB

Exclusion Criteria:

Severe cognitive impairment resulting in the inability to verbally comprehend, learn, and recall new auditory verbal information, as reflected by a TICS score of 20 or less.
Currently participating in counseling and/or psychotherapy more than once a week.
Currently taking anti-psychotic medications
Has been hospitalized for psychiatric reasons in the past six months
Experiencing current active suicidal ideation.
Has received treatment or participated in a clinical trial that involved significant elements of either CBT or hypnosis within the past year.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

22

Study ID:

NCT00621374

Recruitment Status:

Completed

Sponsor:

University of Washington

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Washington
Seattle Washington, 98195, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

22

Study ID:

NCT00621374

Recruitment Status:

Completed

Sponsor:


University of Washington

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider